Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 6/20 | 0.47 |
| ▸ | NPC1 | O15118 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL890759 | 0.82 | KDM4E (0.46) | LMNASMN1; SMN2KDM4EMAPTCYP1A2 | |
| SCHEMBL29367596 | 0.82 | KDM4E (0.46) | LMNASMN1; SMN2KDM4EMAPTCYP1A2 | |
| SCHEMBL10798879 | 0.80 | HTR7 (0.67) | HTR7LMNASMN1; SMN2RAB9ANPC1 | |
| Benzene SCHEMBL22129849 | 0.79 | KDM4E (0.44) | LMNASMN1; SMN2RAB9AKDM4EMAPT | |
| SCHEMBL26646111 | 0.79 | HTR7 (0.59) | HTR7LMNASMN1; SMN2RAB9ANPC1 | |
| SCHEMBL2344935 | 0.78 | HTR7 (0.64) | HTR7LMNASMN1; SMN2RAB9ANPC1 | |
| SCHEMBL701534 | 0.78 | HTR7 (0.64) | HTR7LMNASMN1; SMN2RAB9ANPC1 | |
| SCHEMBL74492 | 0.76 | HTR7 (0.57) | HTR7LMNASMN1; SMN2RAB9ANPC1 | |
| SCHEMBL11107067 | 0.76 | HTR7 (0.52) | HTR7LMNASMN1; SMN2RAB9ANPC1 | |
| SCHEMBL31259416 | 0.76 | HTR7 (0.57) | HTR7LMNASMN1; SMN2RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2994444-B1 | OLIGOMERISATION OF ETHYLENE TO MIXTURES OF 1-HEXENE AND 1-OCTENE | SASOL TECH PTY LTD (ZA) | 2023-04-12 | — | — | EP | disclosed |
| US-9533922-B2 | Oligomerisation of ethylene to mixtures of 1-hexene and 1-octene | SASOL TECHNOLOGY (PROPRIETARY) LIMITED (ZA) | 2017-01-03 | — | — | US | disclosed |
| US-20160083311-A1 | OLIGOMERISATION OF ETHYLENE TO MIXTURES OF 1-HEXENE AND 1-OCTENE | SASOL TECHNOLOGY (PROPRIETARY LIMITED) (ZA) | 2016-03-24 | — | — | US | disclosed |
| EP-2994444-A1 | OLIGOMERISATION OF ETHYLENE TO MIXTURES OF 1-HEXENE AND 1-OCTENE | Sasol Technology (Proprietary) Limited (ZA) | 2016-03-16 | — | — | EP | disclosed |
| EP-1051143-B1 | OXIDIZING HAIR COLORING AGENTS CONTAINING 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES AND NOVEL 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES | WELLA AG (DE) | 2004-07-21 | — | — | EP | disclosed |
| US-6500213-B1 | Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives | WELLA AKTIENGESELLSCHAFT (DE) | 2002-12-31 | — | — | US | disclosed |
| EP-1051143-A2 | OXIDIZING HAIR COLORING AGENTS CONTAINING 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES AND NOVEL 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES | Wella Aktiengesellschaft (DE) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999059527-A2 | OXIDIZING HAIR COLORING AGENTS CONTAINING 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES AND NOVEL 2,5-DIAMINO-1-PHENYLBENZENE DERIVATIVES | WELLA AKTIENGESELLSCHAFT (DE) | 1999-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083311-A1 | OLIGOMERISATION OF ETHYLENE TO MIXTURES OF 1-HEXENE AND 1-OCTENE | LIG1, LIG4, PPIP5K2 | HTR7 1537/4885LMNA 2614/4885SMN1; SMN2 3195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.